Phase 1b OMNIVERSE trial: Safety and tolerability of oral azacitidine (Oral-AZA) in combination with venetoclax (VEN) for treatment of acute myeloid leukemia. A phase II trial of ponatinib and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results